Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

Conditions: Axial Spondyloarthritis Interventions: Biological: anti-TRBV9 monoclonal antibody infusions; Other: Placebo infusions; Drug: Adalimumab subcutaneous injection; Other: Placebo subcutaneous injection Sponsors: Biocad Recruiting

https://clinicaltrials.gov/study/NCT06333210

Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

More News: Humira | Research | Study